Published in Br J Cancer on August 01, 2000
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest (2004) 3.09
Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab (2008) 1.38
Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J Physiol (2007) 1.34
Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction. Mech Ageing Dev (2009) 1.14
Cellular and molecular events controlling skeletal muscle mass in response to altered use. Pflugers Arch (2008) 1.13
Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice. Am J Pathol (2005) 1.10
Loss of IL-15 receptor α alters the endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles. J Clin Invest (2011) 1.05
Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY) (2012) 1.05
Experimental models of hepatocellular carcinoma: developments and evolution. J Cancer Res Clin Oncol (2009) 0.98
Interleukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndrome. Cytokine (2008) 0.98
Leptin in anorexia and cachexia syndrome. Int J Pept (2012) 0.96
Role of NF-kappaB and cytokine in experimental cancer cachexia. World J Gastroenterol (2003) 0.95
Serum and muscle interleukin-15 levels decrease in aging mice: correlation with declines in soluble interleukin-15 receptor alpha expression. Exp Gerontol (2009) 0.92
Systemic elevation of interleukin-15 in vivo promotes apoptosis in skeletal muscles of young adult and aged rats. Biochem Biophys Res Commun (2008) 0.91
Interleukin-15, IL-15 Receptor-Alpha, and Obesity: Concordance of Laboratory Animal and Human Genetic Studies. J Obes (2011) 0.89
Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise. Bone (2015) 0.88
Exercise attenuates the major hallmarks of aging. Rejuvenation Res (2015) 0.87
IL-15 is required for postexercise induction of the pro-oxidative mediators PPARδ and SIRT1 in male mice. Endocrinology (2013) 0.82
IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I: up-regulation of muscle IL-15 by IL-4. Clin Immunol (2009) 0.82
Role of IL-15 in Sepsis-Induced Skeletal Muscle Atrophy and Proteolysis. Tuberc Respir Dis (Seoul) (2012) 0.81
Smokers with CT detected emphysema and no airway obstruction have decreased plasma levels of EGF, IL-15, IL-8 and IL-1ra. PLoS One (2013) 0.80
IL-15Rα deficiency leads to mitochondrial and myofiber differences in fast mouse muscles. Cytokine (2012) 0.80
From anabolic to oxidative: reconsidering the roles of IL-15 and IL-15Rα in skeletal muscle. Exerc Sport Sci Rev (2013) 0.78
Effects of Eccentric and Concentric Emphasized Resistance Exercise on IL-15 Serum Levels and Its Relation to Inflammatory Markers in Athletes and Non-Athletes. Asian J Sports Med (2015) 0.78
Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis. Skelet Muscle (2015) 0.76
Genome-wide association study combined with biological context can reveal more disease-related SNPs altering microRNA target seed sites. BMC Genomics (2014) 0.76
The role of Interleukin 15 in protein degradation in skeletal muscles in rats of chronic obstructive pulmonary disease. Int J Clin Exp Med (2015) 0.75
IL-15 promotes human myogenesis and mitigates the detrimental effects of TNFα on myotube development. Sci Rep (2017) 0.75
Overexpression of interleukin-15 in mice promotes resistance to diet-induced obesity, increased insulin sensitivity, and markers of oxidative skeletal muscle metabolism. Int J Interferon Cytokine Mediat Res (2011) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh) (1972) 7.64
Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell (1984) 6.81
Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science (1994) 6.65
Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J (1994) 5.69
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med (1994) 5.20
Ubiquitin is a heat shock protein in chicken embryo fibroblasts. Mol Cell Biol (1985) 3.31
The effect of protein deprivation and starvation on the rate of protein synthesis in tissues of the rat. Biochim Biophys Acta (1975) 2.73
A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A (1994) 2.51
A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest (1997) 2.37
Interleukin-15 protects from lethal apoptosis in vivo. Nat Med (1997) 2.22
IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol (1995) 2.10
Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology (1996) 1.88
Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology (1995) 1.85
Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res (1991) 1.74
Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2. Cell Immunol (1995) 1.69
Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem J (1986) 1.66
Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest (1993) 1.53
Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem (1993) 1.33
Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett (1994) 1.15
Metabolic approaches to cancer cachexia. Annu Rev Nutr (1982) 1.15
Ubiquitin in stressed chicken embryo fibroblasts. J Biol Chem (1988) 1.14
Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice. Cancer Res (1989) 1.13
Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem J (1987) 1.12
Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. J Clin Invest (1995) 1.09
Cancer cachexia. Br J Cancer (1991) 1.06
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer (1992) 1.06
Increased protein turnover despite normal energy metabolism and responses to feeding in patients with lung cancer. Cancer Res (1990) 1.03
Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer (1993) 1.02
Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Arch Biochem Biophys (1993) 1.01
Protein synthesis in liver tissue under the influence of a methylcholanthrene-induced sarcoma in mice. Cancer Res (1979) 0.98
Protein synthesis in liver and skeletal muscle of mice bearing an ascites tumor. Cancer Res (1984) 0.98
Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats. J Natl Cancer Inst (1993) 0.97
Body composition changes in rats with experimental cancer cachexia: improvement with exogenous insulin. Cancer Res (1988) 0.96
The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Trends Pharmacol Sci (1996) 0.93
Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int J Cancer (1995) 0.92
Increased whole-body protein turnover in sick children with newly diagnosed leukemia or lymphoma. Cancer Res (1983) 0.89
Close association of accelerated rates of whole body protein turnover (synthesis and breakdown) and energy expenditure in children with newly diagnosed acute lymphocytic leukemia. JPEN J Parenter Enteral Nutr (1987) 0.89
Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochem J (1994) 0.88
Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin Sci (Lond) (1994) 0.86
Whole-body protein kinetics in patients with early and advanced gastrointestinal cancer: the response to glucose infusion and total parenteral nutrition. Surgery (1988) 0.86
Influence of the Walker 256 carcinosarcoma on muscle, tumor, and whole-body protein synthesis and growth rate in the cancer-bearing rat. Cancer Res (1986) 0.83
Regulation of protein turnover versus growth state: ascites hepatoma as a model for studies both in the animal and in vitro. Arch Biochem Biophys (1987) 0.83
cDNA cloning and sequencing of component C8 of proteasomes from rat hepatoma cells. Biochem Biophys Res Commun (1990) 0.83
Immunolocalization of ubiquitin conjugates at Z-bands and intercalated discs of rat cardiomyocytes in vitro and in vivo. J Histochem Cytochem (1992) 0.81
Host and tumor responses to varying rates of nitrogen infusion in the tumor-bearing rat. Ann Surg (1988) 0.80
Protein turnover states of tumour cells and host tissues in an experimental model. Biomed Biochim Acta (1986) 0.79
Comparative studies on protein turnover regulations in tumor cells and host tissues: development and analysis of an experimental model. Toxicol Pathol (1986) 0.79
Chronic tumour necrosis factor-alpha treatment modifies protein turnover in rat tissues. Biochem Mol Biol Int (1993) 0.79
Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol (1984) 2.33
Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.30
Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med (1993) 2.18
Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab (2004) 1.94
Effect of microtubular or translational inhibitors on general cell protein degradation. Evidence for a dual catabolic pathway. Biochem J (1977) 1.93
Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells. Carcinogenesis (1993) 1.80
Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. Clin Infect Dis (1996) 1.64
LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. Blood (2000) 1.64
Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia. Intensive Care Med (2002) 1.57
Cancer cachexia: from experimental models to patient management. Curr Opin Clin Nutr Metab Care (2000) 1.54
Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest (1993) 1.53
A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission. Intensive Care Med (1996) 1.43
Physician performance in a prepaid health plan: results of the peer review program of the Health Insurance Plan of Greater New York. Med Care (1982) 1.43
Short-term effects of carbon dioxide on carnation callus cell respiration. Plant Physiol (1991) 1.34
Delayed sleep phase syndrome response to melatonin. Lancet (1991) 1.33
Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem (1993) 1.33
Analysis of cellular immune response in pigs recovered from porcine respiratory and reproductive syndrome infection. Virus Res (1999) 1.32
Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo. FASEB J (2000) 1.28
Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J (2003) 1.27
Studies on the structure-bound sedimentabolity of some rat liver lysosome hydrolases. Biochem J (1971) 1.23
Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun (1999) 1.23
Isolation and clonal analysis of satellite cells from chicken pectoralis muscle. Dev Biol (1987) 1.23
Nitration and inactivation of tyrosine hydroxylase by peroxynitrite. J Biol Chem (2001) 1.22
Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer (1994) 1.20
Pathways of peroxynitrite oxidation of thiol groups. Biochem J (1997) 1.19
Generation of chick skeletal muscle cells in groups of 16 from stem cells. Nature (1985) 1.18
TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun (1997) 1.17
Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett (1994) 1.15
Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine. Cephalalgia (1994) 1.15
Metabolic effects of tumour necrosis factor-alpha (cachectin) and interleukin-1. Clin Sci (Lond) (1989) 1.15
Tumour necrosis factor-alpha increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett (1993) 1.13
Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem J (1987) 1.12
Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. Exp Cell Res (1995) 1.12
Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Invest (2008) 1.11
Purification and characterization of a psychrophilic, calcium-induced, growth-phase-dependent metalloprotease from the fish pathogen Flavobacterium psychrophilum. Appl Environ Microbiol (2001) 1.10
The metabolic basis of cancer cachexia. Med Res Rev (1997) 1.10
Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. J Clin Invest (1995) 1.09
Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer (2009) 1.09
The role of cytokines in cancer cachexia. Med Res Rev (1999) 1.08
Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice. Mol Cell Endocrinol (1998) 1.07
Inhibition of basal protein degradation in rat embryo fibroblasts by cycloheximide: correlation with activities of lysosomal proteases. J Cell Physiol (1978) 1.07
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer (1992) 1.06
Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia. Br J Cancer (2001) 1.03
Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer (1993) 1.02
Direct effects of doxorubicin on skeletal muscle contribute to fatigue. Br J Cancer (2009) 1.02
Structural equivalents of latency for lysosome hydrolases. Biochem J (1975) 1.02
Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim Biophys Acta (2001) 1.02
Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice. Curr Cancer Drug Targets (2009) 1.01
Control of cell protein degradation. Changes in activities of lysosomal proteases. Biochim Biophys Acta (1977) 1.01
Muscle wasting in cancer and ageing: cachexia versus sarcopenia. Adv Gerontol (2006) 1.01
Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Arch Biochem Biophys (1993) 1.01
Ubiquitin gene expression in skeletal muscle is increased by tumour necrosis factor-alpha. Biochem Biophys Res Commun (1994) 1.01
Insulin and cancer (Review). Int J Oncol (2001) 1.00
Partial characterization of skeletal myoblast mitogens in mouse crushed muscle extract. J Cell Physiol (1992) 1.00
Ubiquitin gene expression in skeletal muscle is increased during sepsis: involvement of TNF-alpha but not IL-1. Biochem Biophys Res Commun (1995) 0.99
Sulfenic acid in human serum albumin. Amino Acids (2006) 0.99
Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regul Integr Comp Physiol (2001) 0.99
Porcine myelomonocytic markers and cell populations. Dev Comp Immunol (2008) 0.99
Altered pattern of lipid metabolism in patients with lung cancer. Oncology (1992) 0.98
Naming times for the Snodgrass and Vanderwart pictures in Spanish. Behav Res Methods Instrum Comput (1999) 0.97
Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett (1998) 0.97
Amino acid metabolism in tumour-bearing mice. Biochem J (1988) 0.97